2-201492160-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001168221.2(C2CD6):c.4181C>A(p.Thr1394Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000636 in 1,524,978 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001168221.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C2CD6 | NM_001168221.2 | c.4181C>A | p.Thr1394Asn | missense_variant | 15/16 | ENST00000439140.6 | NP_001161693.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C2CD6 | ENST00000439140.6 | c.4181C>A | p.Thr1394Asn | missense_variant | 15/16 | 1 | NM_001168221.2 | ENSP00000409937.1 | ||
C2CD6 | ENST00000286195.7 | c.1581+3735C>A | intron_variant | 1 | ENSP00000286195.3 | |||||
C2CD6 | ENST00000439802.5 | c.*49+3735C>A | intron_variant | 2 | ENSP00000400672.1 | |||||
C2CD6 | ENST00000482942.1 | n.101-4258C>A | intron_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000921 AC: 14AN: 152022Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000207 AC: 27AN: 130646Hom.: 0 AF XY: 0.000286 AC XY: 20AN XY: 70012
GnomAD4 exome AF: 0.0000605 AC: 83AN: 1372956Hom.: 0 Cov.: 33 AF XY: 0.0000798 AC XY: 54AN XY: 677054
GnomAD4 genome AF: 0.0000921 AC: 14AN: 152022Hom.: 0 Cov.: 32 AF XY: 0.0000943 AC XY: 7AN XY: 74260
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.4181C>A (p.T1394N) alteration is located in exon 15 (coding exon 15) of the ALS2CR11 gene. This alteration results from a C to A substitution at nucleotide position 4181, causing the threonine (T) at amino acid position 1394 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at